The Valley Desk

NCT03654716 · Interventional trial

Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer

Overall registry status Completed

Phase 1

Conditions Brain Tumor, Leukemia, Lymphoma, Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov